Clinical Diabetes

H2HUBB PLAIN-LANGUAGE TAKEAWAY The study adds to the molecular-hydrogen evidence base, but the available record does not support a firm conclusion about therapeutic benefit. Molecular hydrogen diabetes study: what the findings mean This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. The publication “Clinical Diabetes” was classified as […]

Read More

Anti-diabetes effect of water containing hydrogen molecule and Pt nanoparticles.

In an animal model, electrochemically reduced water (ERW) contains a lot of hydrogen molecule (H₂ ) and scavenges reactive oxygen species (ROS) to protect DNA from oxidative damage. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.

Read More

Hydrogen improves glycemic control in type1 diabetic animal model by promoting glucose uptake into skeletal muscle.

This publication is an erratum or correction associated with a molecular-hydrogen article. It does not report a new standalone experiment.

Read More

Protective effects of hydrogen saline on diabetic retinopathy in a streptozotocin-induced diabetic rat model.

H(2) saline treatment could depress the caspase activity, reduce the retinal apoptosis, and vascular permeability. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.

Read More